United States · FDA National Drug Code directory
TOPICAINE 5
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63135-581_47e9cb0c-dbdb-3ee0-e063-6394a90a9052
- Product NDC
- 63135-581
- Form
- GEL
- Composition / generic term
- LIDOCAINE 5%
- Labeler
- ESBA LABORATORIES INC.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20030420
- Source listing expiry
- 20271231
Source-listed ingredients
- LIDOCAINE — 5 g/100g
These values do not establish equivalence or a dose recommendation.
Packages
- 113 g in 1 TUBE (63135-581-04) · 63135-581-04
- 1 TUBE in 1 BOX (63135-581-10) / 10 g in 1 TUBE · 63135-581-10
- 1 TUBE in 1 BOX (63135-581-30) / 30 g in 1 TUBE · 63135-581-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →